TME Therapeutics Inc. (TME) and Sanwa Kagaku Kenkyusho Co., Ltd. (SKK) have reached an agreement for TME to license its oligonucleotide product candidate to SKK.
TME Therapeutics Inc. (TME) and Sanwa Kagaku Kenkyusho Co., Ltd. (SKK) have reached an agreement for TME to license its oligonucleotide product candidate to SKK.